Healthcare Stocks
Pure Biologics To Get 32.4 Mln Zloty Subsidy For PB004 Pure Bike Project
- January 23, 2023 08:27 AM CET | Reuters

Jan 23 (Reuters) - Pure Biologics SA: * SIGNS DEAL WITH MEDICAL RESEARCH AGENCY FOR EXECUTION AND SUBSIDY FOR PB004 PURE BIKE PROJECT * VALUE OF SUBSIDY AT 32.4 MILLION ZLOTYS Source text for Eikon:
Nanogroup Unit Gets Results On System Of Organ Perfusion Intended For Transplant
- January 19, 2023 12:32 PM CET
- Reuters
Synektik Management Recommends 0.60 Zloty/Shr Dividend
- January 19, 2023 10:34 AM CET
- Reuters
Selvita Holds Shares Representing 46.22% Of Voting Rights In Ardigen
- January 18, 2023 05:12 PM CET
- Reuters
'Not right' for us to be key global health funder -Gates CEO
- January 17, 2023 06:01 AM CET
- Reuters

Davos 2023-New regulatory definitions needed for digital assets -Circle CEO
- January 16, 2023 08:17 PM CET | Reuters
By Divya Chowdhury and Lisa Pauline Mattackal Jan 16 (Reuters) - Major markets such as the United States need new statutory definitions of digital assets to provide regulatory clarity for the sector,
Read More...
Canada's Ontario Province To Expand Scope Of Private Clinics Under Plan To Shorten Health Care Backlog
- January 16, 2023 04:46 PM CET | Reuters
Jan 16 (Reuters) - * CANADA'S ONTARIO PROVINCE TO EXPAND SCOPE OF COMMUNITY HEALTH CLINICS TO ADDRESS REGIONAL HEALTHCARE NEEDS -PREMIER FORD * ONTARIO GOVERNMENT TO INTRODUCE LEGISLATION IN FEBRUARY
Read More...
Poltreg To Get 31.7 Mln Zloty Subsidy For Prediabetes Cellular Therapy Project
- January 16, 2023 02:33 PM CET | Reuters
Jan 16 (Reuters) - Poltreg SA: * SIGNS DEAL WITH POLAND'S MEDICAL RESEARCH AGENCY (ABM) FOR 31.7 MILLION ZLOTY SUBSIDY * SUBSIDY FOR PREDIABETES CELLULAR THERAPY PROJECT * PROJECT'S TOTAL ELIGIBLE
Read More...
Biomaxima Gets 1.8 Mln Subsidy To Buy Production Line
- January 16, 2023 10:42 AM CET | Reuters
Jan 16 (Reuters) - BioMaxima SA: * RECEIVES 1.8 MILLION SUBSIDY FOR PURCHASE OF PRODUCTION LINE * SUBSIDY FOR PRODUCTION LINE OF TESTS FOR IDENTIFICATION OF SARS-COV-2 * INVESTMENT TO GIVE POTENTIAL
Read More...
Press Release: AbbVie, Eli Lilly exit UK drug pricing agreement
- January 16, 2023 10:24 AM CET | Reuters
(Adds details, background) Jan 16 (Reuters) - Pharmaceutical companies AbbVie and Eli Lilly have withdrawn from Britain's voluntary medicines pricing agreement, an industry body said on Monday.
Read More...
AbbVie, Eli Lilly exit UK drug pricing agreement
- January 16, 2023 09:58 AM CET | Reuters
(Reuters) - Pharmaceutical companies AbbVie and Eli Lilly have withdrawn from Britain's voluntary medicines pricing agreement, an industry body said on Monday. Companies are increasingly arguing that
Read More...
Press Release: AbbVie, Eli Lilly exit UK drug pricing agreement
- January 16, 2023 09:54 AM CET | Reuters
Jan 16 (Reuters) - Pharmaceutical companies AbbVie and Eli Lilly have withdrawn from Britain's voluntary medicines pricing agreement, an industry body said on Monday. Companies are increasingly
Read More...
WHO says its chief spoke with Chinese officials, welcomes COVID-19 data
- January 14, 2023 08:45 PM CET | Reuters
ZURICH (Reuters) - The World Health Organization's head has spoken with Chinese authorities and the agency welcomed new information about the situation in the country, WHO said on Saturday after
Read More...
U.S. Supreme Court to weigh key standard in whistleblower fraud cases
- January 13, 2023 11:51 PM CET | Reuters
By Brendan Pierson Jan 13 (Reuters) - The U.S. Supreme Court on Friday agreed to consider reviving two lawsuits accusing pharmacy operators of overbilling government health insurance programs for
Read More...
Biden administration vaccine drive leader David Kessler to step down
- January 13, 2023 09:30 PM CET | Reuters
Jan 13 (Reuters) - David Kessler, who led the COVID-19 vaccine distribution efforts for the United States, is stepping down from President Joe Biden's administration, the Department of Health and
Read More...